Literature DB >> 30125970

Development of reference material with assigned value for human T-cell leukemia virus type 1 quantitative PCR in Japan.

Madoka Kuramitsu1, Kazu Okuma1, Makoto Nakashima2, Tomoo Sato3, Daisuke Sasaki4, Hiroo Hasegawa4, Kazumi Umeki5, Ryuji Kubota6, Keiko Sasada7, Rieko Sobata8, Chieko Matsumoto8, Noriaki Kaneko9, Kenta Tezuka1, Sahoko Matsuoka1, Atae Utsunomiya10, Ki-Ryang Koh11, Masao Ogata12, Kenji Ishitsuka13, Mai Taki14, Kisato Nosaka15, Kaoru Uchimaru2,16, Masako Iwanaga17, Yasuko Sagara18, Yoshihisa Yamano3, Akihiko Okayama5, Kiyonori Miura19, Masahiro Satake8, Shigeru Saito20, Toshiki Watanabe2,21, Isao Hamaguchi1.   

Abstract

Quantitative PCR (qPCR) of human T-cell leukemia virus type 1 (HTLV-1) provirus is used for HTLV-1 testing and for assessment of risk of HTLV-1-related diseases. In this study, a reference material was developed for standardizing HTLV-1 qPCR. Freeze-dried TL-Om1 cells diluted with Jurkat cells were prepared and an assigned value for proviral load (PVL) of 2.71 copies/100 cells was determined by digital PCR. Nine Japanese laboratories using their own methods evaluated the PVLs of this reference material as 1.08-3.49 copies/100 cells. The maximum difference between laboratories was 3.2-fold. Correcting measured PVLs by using a formula incorporating the assigned value of this reference material should minimize such discrepancies.
© 2018 The Societies and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  human T-cell leukemia virus type 1; proviral load; quantitative PCR; standard

Mesh:

Substances:

Year:  2018        PMID: 30125970     DOI: 10.1111/1348-0421.12644

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  4 in total

1.  HTLV-1 targets human placental trophoblasts in seropositive pregnant women.

Authors:  Kenta Tezuka; Naoki Fuchi; Kazu Okuma; Takashi Tsukiyama; Shoko Miura; Yuri Hasegawa; Ai Nagata; Nahoko Komatsu; Hiroo Hasegawa; Daisuke Sasaki; Eita Sasaki; Takuo Mizukami; Madoka Kuramitsu; Sahoko Matsuoka; Katsunori Yanagihara; Kiyonori Miura; Isao Hamaguchi
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

2.  Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1.

Authors:  Yukie Tanaka; Tomoo Sato; Naoko Yagishita; Junji Yamauchi; Natsumi Araya; Satoko Aratani; Katsunori Takahashi; Yasuo Kunitomo; Misako Nagasaka; Yoshinobu Kanda; Kaoru Uchimaru; Tomohiro Morio; Yoshihisa Yamano
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

3.  Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Misako Nagasaka; Makoto Yamagishi; Naoko Yagishita; Natsumi Araya; Seiichiro Kobayashi; Junya Makiyama; Miyuki Kubokawa; Junji Yamauchi; Daisuke Hasegawa; Ariella L G Coler-Reilly; Shuntaro Tsutsumi; Yu Uemura; Ayako Arai; Ayako Takata; Eisuke Inoue; Yasuhiro Hasegawa; Toshiki Watanabe; Yutaka Suzuki; Kaoru Uchimaru; Tomoo Sato; Yoshihisa Yamano
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-11       Impact factor: 11.205

4.  Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.

Authors:  Kazu Okuma; Madoka Kuramitsu; Toshihiro Niwa; Tomokuni Taniguchi; Yumiko Masaki; Gohzoh Ueda; Chieko Matsumoto; Rieko Sobata; Yasuko Sagara; Hitomi Nakamura; Masahiro Satake; Kiyonori Miura; Naoki Fuchi; Hideaki Masuzaki; Akihiko Okayama; Kazumi Umeki; Yoshihisa Yamano; Tomoo Sato; Masako Iwanaga; Kaoru Uchimaru; Makoto Nakashima; Atae Utsunomiya; Ryuji Kubota; Kenji Ishitsuka; Hiroo Hasegawa; Daisuke Sasaki; Ki-Ryang Koh; Mai Taki; Kisato Nosaka; Masao Ogata; Isao Naruse; Noriaki Kaneko; Sara Okajima; Kenta Tezuka; Emi Ikebe; Sahoko Matsuoka; Kazuo Itabashi; Shigeru Saito; Toshiki Watanabe; Isao Hamaguchi
Journal:  Retrovirology       Date:  2020-08-24       Impact factor: 4.602

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.